Detection of Colorectal Adenomas in Côte-d'Or

Colorectal Adenoma Clinical Trial

— DACCOR  

Official title:

Detection of Colorectal Adenomas in Côte-d'Or: Impact of Organized Screening on Socio-geographic Disparities

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02859714
• Other study ID #: COTTET PARI 2015
• Status: Not yet recruiting
• Phase: N/A
• First received: August 1, 2016
• Last updated: August 4, 2016

Study information

• Verified date: July 2016
• Source: Centre Hospitalier Universitaire Dijon
• Contact: Vanessa COTTET
• Phone: 03.80.39.34.87
• Email: vanessa.cottet[@]chu-dijon.fr
• Is FDA regulated: No
• Health authority: France: Agence Nationale de Sécurité du Médicament et des produits de santé
• Study type: Observational

Clinical Trial Summary

Previous studies have shown geographic disparities in the detection of colorectal adenomas in Côte-d'Or, with an impact of the distance from the general practitioner and an ecological deprivation index (EDI). On the other hand, the extremely low detection rates for these lesions in everyday practice before the implementation of organized screening for colorectal cancer in the Côte-d'Or were shown. One of the aims of this screening is to reduce socio-geographic inequalities in access to care and prevention. Yet, participation in screening also varies depending on the socio-economic level. In this context, the Côte-d'Or Polyps Registry, the only body to have data for the pre-screening period (before 2003), will make it possible to determine whether the implementation of organized screening led to the elimination of socio-geographic disparities concerning the detection of adenomas.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 11600
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 50 Years to 74 Years

Eligibility

Inclusion Criteria:

• The study population will include all patients residing in Côte d'Or with a first colorectal adenoma (including in situ carcinomas) diagnosed between 01/01/1997 and 31/12/2008

Exclusion Criteria:

• Absence of address

• history (or suspected history) of previously resected adenoma

• personal history of colorectal cancer or colorectal cancer discovered in the year following resection of the adenoma (because the cancer was probably not seen at the initial colonoscopy)

• familial polyposis or known HNPCC

• chronic inflammatory bowel disease

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Adenoma
• Colorectal Adenoma

Intervention

Other:
• screening data

Locations

Country	Name	City	State
France	CHU Dijon Bourgogne	Dijon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detection rates for colorectal adenomas		through the study completion up to 2 years	No